Navigation Links
Islet Sciences Announces Exclusive License Agreement with Winthrop University Hospital to Commercialize a Beta Cell Loss Measurement Technology in Diabetes
Date:9/10/2012

, Chief Research Officer, Director of the Diabetes, Obesity and Cardiometabolic Research Center and Senior Scientist, Winthrop University Hospital Research Institute commented, "We look forward to working with Islet Sciences as they invest in this discovery and develop it into a valuable new tool for treating this life altering disease."

About Islet Sciences, Inc.
Islet Sciences is a development-stage biotechnology company with patented technologies focused on transplantation therapy for people with insulin-dependent diabetes.  The Company's transplantation technology includes methods for the culturing, isolation, maturation, and immunoprotection (microencapsulation) of islet cells. The Company's mission includes the introduction of commercial products with applications to cell-based replacement therapy in the healthcare marketplace. www.isletsciences.com

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements for Islet Sciences reflect current expectations, as of the date of this press release, and involve certain risks and uncertainties.   Actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors.  Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the risks described in the Islet Science's reports filed with the Securities and Exchange Commission.  The companies' further development is highly dependent on future medical and research developments and market acceptance, which is outside their control.

Investor Contact:
Jeff Ramson
ProActive Capital Resources Group
(646) 863-6893
jramson@proactivecrg.com


'/>"/>
SOURCE Islet Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Islet Sciences, Inc. Selects NeoStems Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
2. Islet Sciences Announces DiaKine Therapeutics Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection
3. Islet Sciences Announces Receipt of $2.1 Million in Grant Support of Technology
4. Islet Sciences Names Richard A. Franco, Sr. to its Board of Directors
5. Garage Start-ups Now Possible in Life Sciences Industry
6. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
7. DiaTech Life Sciences Announces Medical Advisory Board
8. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
9. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
10. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
11. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... DIEGO , May 23, 2013  Verenium Corporation ... company focused on the development and commercialization of high-performance ... , Chief Financial Officer, will present at two upcoming ... Mr. Black will present at the Second Annual Marcum ... the Grand Hyatt Hotel in New York City.  The ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Bed bugs already ... the pests is still ongoing, a report from kmov.com suggested ... for the bed bug treatment. Meanwhile, to be of help, ... from the costly bed bug exterminator service. , ... that AHA has so far spent $35,000 for ...
(Date:5/22/2013)... Oven Industries announces the new 5R1-1400 ... or via a PC through the TTL level UART ... half inches square can deliver up to 15 AMPS ... noise solid state relay. Operator safety is achieved with ... port and sensor input. Specifications: Input Voltage 85 ...
(Date:5/22/2013)... NEW YORK , May 22, 2013 /PRNewswire/ ... pioneering the development of disease modifying therapeutics for ... today the completion of its Series B financing, ... shares and warrants that would represent approximately $2.8M ... investors and new investors supported the raise. ...
Breaking Biology Technology:Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3Bed Bug Exterminator Service Could Cost AHA $250K, My Cleaning Products Gives Tips How to Save Apartments from Costly Bed Bug Treatment 2New AC Temperature Controller Announced by Oven Industries 2Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3
... Pharmaceuticals,Inc. (Nasdaq: CADX ), a biopharmaceutical company ... principally,for use in the hospital setting, today announced ... year ended December 31, 2007 financial results,after the ... Cadence management will host a conference call ...
... PXS; Nasdaq: PXSL) today announced that a clinical ... accepted for evaluation by,China,s State Food and Drug ... to undertake a study in a,Chinese population to ... trial application is expected in the fourth,quarter of ...
... Provides R&D Pipeline Update -, IRVINE, Calif., March 6 ... results for the year ended,December 31, 2007. ISTA reported net ... a 78% increase over the full-year 2006 results of,$33.0 million. ... over,the fourth quarter of 2006., "2007 was a year ...
Cached Biology Technology:Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008 2Pharmaxis' First Steps into China 2ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 2ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 3ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 4ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 5ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 6ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 7ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 8
(Date:5/22/2013)... whole organism, as they may lead to life-threatening illnesses ... report how byproducts of respiration cause mispairing of subunits ... cells controls the form and function of every cell ... encoded in the linear sequence of the four subunits ... guanine (G) and thymine (T). Random changes in the ...
(Date:5/22/2013)... pollinating insects and wild plants have slowed in recent ... by the University of Leeds and the Naturalis Biodiversity ... reductions in the diversity of species in Britain, Belgium ... But the picture brightened markedly after 1990, with a ... hoverflies and wild plants. , Professor Bill ...
(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...
Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
... people lacking access to clean, safe drinking water, scientists ... inexpensive new filtering technology that kills up to 98 ... clogging. A report on the technology appears in ... Yi Cui and colleagues explain that most ...
... why an arsenic compound, called arsenite, can kill us, ... disease and infections. According to new research published in ... http://www.genetics.org ) scientists from Johns Hopkins, Baylor and Stanford ... parts of the world, affects a special protein folding ...
... Unlike humans, honey bees, when thrown into highly time-altered new ... alacrity, enabling them to make a successful "quick switch" in ... Hebrew University of Jerusalem. With people, on ... changes in their daily schedules are known to cause problems ...
Cached Biology News:Scientists solve mystery of arsenic compound 2Unlike us, honeybees naturally make 'quick switch' in their biological clocks, says Hebrew University researcher 2
... described by end-users to be "a delight ... of light microscopy and electronic imaging. With ... does not require much space and can ... environment. The DM-BA300 combines Motic's own revolutionary ...
lid holder -see Blotters (Semi-Dry) for more info...
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human CD69 TAC is designed to deplete human CD69 from samples to isolate resting CD4+ or CD8+ T cells....
... Aquarius 384 is a compact and ... head is a unique flow-through device, ... the included wash system. Optional ... stacker system. Will be upgradable ...
Biology Products: